MedTrace Logo

LUPS-Lipids and Glucose Under Prospective Surveillance

NCT01313156 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1962

Last updated 2019-08-09

No results posted yet for this study

Summary

Prospective, non-randomized cohort study to analyse genetic variations, dietary patterns, perceived stress and anxiety and early changes in lipid metabolism leading to the metabolic syndrome and type 2 diabetes

Conditions

Sponsors & Collaborators

  • City of Hamburg

    collaborator OTHER_GOV

  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER

  • Asklepios proresearch

    lead INDUSTRY

Principal Investigators

  • Dirk Mueller-Wieland, Prof., MD · Asklepios Klinik St.Georg, Hamburg, Germany

  • Karl Wegscheider, Prof., PHD · Universitätsklinikum Hamburg-Eppendorf, Germany

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01313156 on ClinicalTrials.gov